Results 101 to 110 of about 5,696 (226)

True hermaphroditism with dysgerminoma

open access: yesMedicine, 2020
Introduction: True hermaphroditism is a rare and usually sporadic disorder. It is defined by the presence of both ovarian and testicular tissues together as ovotestis.
Chun-Qiao Chen   +4 more
semanticscholar   +1 more source

Fear of Progression in Pediatric Cancer Patients and Their Parents: Trajectories, Prevalence, and Correlates Across Acute Treatment and Follow‐Up Care

open access: yesPsycho-Oncology, Volume 35, Issue 6, June 2026.
ABSTRACT Purpose Fear of progression (FoP) represents a significant psychological burden for pediatric cancer patients and their parents. This study investigates FoP levels across acute treatment (AcT) and follow‐up care (FuC) and examines trajectories over time, associated sociodemographic factors, and parent‐child associations.
Jessy Herrmann   +6 more
wiley   +1 more source

Ovarian Dysgerminoma Presenting With Secondary Amenorrhoea: Case Report

open access: yes, 2005
A rare case of ovarian dysgerminoma presenting with ...
Nwana, Edmund J   +7 more
core   +1 more source

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, Volume 73, Issue 5, May 2026.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Dysgerminoma and granulosa cell tumor in a bitch

open access: yesBrazilian Journal of Veterinary Pathology, 2016
Dysgerminoma and granulosa cell tumor are neoplasms of the ovary of domestic animals, originating from germ cells and sex-cords cells, respectively. These neoplasms generally occur unilaterally, and usually as a single neoplasm.
Ayisa R. Oliveira   +8 more
doaj   +1 more source

Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?

open access: yesGynecologic Oncology, 2018
OBJECTIVE Dysgerminoma is the most common malignant ovarian germ cell tumor (GCT) with peak incidence during adolescence and young adulthood. Current standard of care for patients with disease that has spread outside of the ovary (advanced-stage ...
R. Shah   +19 more
semanticscholar   +1 more source

Precision Oncology for Pediatric Solid Tumors Using In‐Hospital Pediatric/AYA Malignancy‐Specific Panel Sequencing

open access: yesCancer Science, Volume 117, Issue 3, Page 797-806, March 2026.
Our findings indicate that a pediatric/AYA‐specific targeted panel deployed in a hospital can deliver rapid, clinically actionable molecular insights with high diagnostic and prognostic yield. This complements larger sequencing platforms by offering speed, focused content, and easier interpretation.
Masato Kojima   +8 more
wiley   +1 more source

Imaging of gynecological disease (6): Clinical and ultrasound characteristics of ovarian dysgerminoma

open access: yes, 2011
Objectives To describe the clinical history and ultrasound findings in patients with ovarian dysgerminoma. Methods This was a retrospective study of patients with a histological diagnosis of ovarian dysgerminoma who had undergone preoperative ultrasound ...
Franchi, D.   +15 more
core   +4 more sources

Long‐term outcome in a dog with a unilateral ovarian granulosa cell tumour with a concurrent non‐neoplastic abdominal effusion following ovariohysterectomy

open access: yesVeterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract An 8‐year‐old, entire, female Boston terrier presented with chronic abdominal distention and acute anorexia. Physical examination identified a palpable abdominal mass and ascites. Results of haematological and serum biochemical investigations were within reference range.
Toshiyuki Tanaka   +2 more
wiley   +1 more source

Outcome and Reproductive Function After Chemotherapy for Ovarian Dysgerminoma

open access: yes, 1999
PURPOSE: To review the outcome for all patients with ovarian dysgerminoma treated at the M.D. Anderson Cancer Center who received bleomycin, etoposide, and cisplatin (BEP) and to assess the menstrual and reproductive function of those who received ...
Elvio G. Silva   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy